2025-03-12 18:11:06
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Anuh Pharma Ltd Q2 FY23 net profit higher at Rs. 9.91 crores
Posted On : 2022-11-07 15:50:47( TIMEZONE : IST )
ANUH PHARMA LTD. has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 117.0795 crores during the period ended September 30, 2022 as compared to Rs. 117.3315 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 9.9152 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 7.3353 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 1.98 for the period ended September 30, 2022 as compared to Rs. 1.46 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 117.0795 crs | ₹117.3315 crs |  -0.21% |
| Net Profit | ₹9.9152 crs | ₹7.3353 crs |  35.17% |
| EPS | ₹1.98 | ₹1.46 | 35.62% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 117.0795 crores during the period ended September 30, 2022 as compared to Rs.110.6455 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.9.9152 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.8.5974 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.1.98 for the period ended September 30, 2022 as compared to Rs.1.72 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 117.0795 crs | ₹110.6455 crs | 5.81% |
| Net Profit | ₹9.9152 crs | ₹8.5974 crs | 15.33% |
| EPS | ₹1.98 | ₹1.72 | 15.12% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.234.4110 crores during the 6 Months period ended September 30, 2022 as compared to Rs.229.8417 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.17.2505 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.14.1877 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.3.44 for the 6 Months period ended September 30, 2022 as compared to Rs.2.83 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹234.4110 crs | ₹229.8417 crs | 1.99% |
| Net Profit | ₹17.2505 crs | ₹14.1877 crs | 21.59% |
| EPS | ₹3.44 | ₹2.83 | 21.55% |
Shares of ANUH PHARMA LTD. was last trading in BSE at Rs. 92.20 as compared to the previous close of Rs. 91.05. The total number of shares traded during the day was 11014 in over 143 trades.
The stock hit an intraday high of Rs. 92.75 and intraday low of 90.75. The net turnover during the day was Rs. 1009825.00.
